BIOMARIN PHARMACEUTICAL INC — Form 8-K
Filed September 15, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 8/100
What the filing says
BioMarin Pharmaceutical filed an 8-K on 2026-09-15 disclosing Item 8.01 (Other Events). The filing document itself does not contain the substantive disclosure text—only the EDGAR header and XBRL metadata are visible. No specific counterparties, dollar amounts, dates, or business changes are stated in the accessible portion of this filing.
Why this rating
Content of Item 8.01 not provided in filing text; cannot assess materiality. Routine 8-K filing structure suggests routine disclosure.
Extracted items
See more from September 15, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.